Salinomycin inhibits the tumor growth of glioma stem cells by selectively suppressing glioma-initiating cells (Q35111314)

6 August 2017

title

Salinomycin inhibits the tumor growth of glioma stem cells by selectively suppressing glioma-initiating cells (English)

1 reference

6 August 2017

Tunan Chen

1

1 reference

6 August 2017

Liang Yi

2

1 reference

6 August 2017

Fei Li

3

1 reference

6 August 2017

Rong Hu

4

1 reference

6 August 2017

Shengli Hu

5

1 reference

6 August 2017

Yi Yin

6

1 reference

6 August 2017

Chuan Lan

7

1 reference

6 August 2017

Zhao Li

8

1 reference

6 August 2017

Chuhua Fu

9

1 reference

6 August 2017

Liu Cao

10

1 reference

6 August 2017

Zhi Chen

11

1 reference

6 August 2017

Jishu Xian

12

1 reference

6 August 2017

Hua Feng

13

1 reference

6 August 2017

publication date

1 December 2014

1 reference

Molecular Medicine Reports

6 August 2017

published in

1 reference

6 August 2017

volume

11

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

2407-2412

1 reference

Implantation of GL261 neurospheres into C57/BL6 mice: a more reliable syngeneic graft model for research on glioma-initiating cells

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Glioma-initiating cells and molecular pathology: implications for therapy

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Identification of selective inhibitors of cancer stem cells by high-throughput screening

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Malignant gliomas in adults

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Glioma stem cells: a midterm exam.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Mechanisms of chemoresistance to alkylating agents in malignant glioma

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

9 July 2018

Brain tumour stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Identification of human brain tumour initiating cells

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Identification of a cancer stem cell in human brain tumors

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Salinomycin, a new polyether antibiotic.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Salinomycin Effects on Mitochondrial Ion Translocation and Respiration

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

Chemotherapy resistance of glioblastoma stem cells

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337630

27 September 2018

Identifiers

DOI

10.3892/MMR.2014.3027

1 reference

6 August 2017

1 reference

6 August 2017

1 reference